⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

OCS News

Oculis Holding AG Ordinary shares

Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis